[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003205555A1 - Management of mucosal viscosity by tff monomer peptides - Google Patents

Management of mucosal viscosity by tff monomer peptides

Info

Publication number
AU2003205555A1
AU2003205555A1 AU2003205555A AU2003205555A AU2003205555A1 AU 2003205555 A1 AU2003205555 A1 AU 2003205555A1 AU 2003205555 A AU2003205555 A AU 2003205555A AU 2003205555 A AU2003205555 A AU 2003205555A AU 2003205555 A1 AU2003205555 A1 AU 2003205555A1
Authority
AU
Australia
Prior art keywords
tff
management
monomer peptides
mucosal viscosity
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205555A
Inventor
Steen Seier Poulsen
Lars Thim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003205555A1 publication Critical patent/AU2003205555A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1735Mucins, e.g. human intestinal mucin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003205555A 2002-02-11 2003-02-10 Management of mucosal viscosity by tff monomer peptides Abandoned AU2003205555A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200200200 2002-02-11
DKPA200200200 2002-02-11
PCT/DK2003/000083 WO2003068817A1 (en) 2002-02-11 2003-02-10 Management of mucosal viscosity by tff monomer peptides

Publications (1)

Publication Number Publication Date
AU2003205555A1 true AU2003205555A1 (en) 2003-09-04

Family

ID=27675518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205555A Abandoned AU2003205555A1 (en) 2002-02-11 2003-02-10 Management of mucosal viscosity by tff monomer peptides

Country Status (4)

Country Link
EP (1) EP1476466A1 (en)
JP (1) JP2005524641A (en)
AU (1) AU2003205555A1 (en)
WO (1) WO2003068817A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
WO2005042010A1 (en) * 2003-10-30 2005-05-12 Novo Nordisk A/S Use of trefoil polypeptides in the treatment of diabetes
US20100196433A1 (en) * 2005-06-02 2010-08-05 Williams Stuart K Prevascularized devices and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
DK6893D0 (en) * 1993-01-21 1993-01-21 Novo Nordisk As PEPTIDE
BR9508773A (en) * 1994-08-26 1997-12-30 Novo Nordisk As Trifoliate peptide process of preparing a trifoliate peptide dimer pharmaceutical composition trifoliate peptide dimer and use of a trifoliate peptide dimer
DE60044957D1 (en) * 1999-07-05 2010-10-21 Actogenix Nv Provision of cloverleaf peptides
JP2005503340A (en) * 2001-04-24 2005-02-03 ザ ジェネラル ホスピタル コーポレーション Methods and compositions for the treatment of oral and esophageal lesions
EP1401481A1 (en) * 2001-06-14 2004-03-31 Novo Nordisk A/S Mucosal repair by tff dimer peptides

Also Published As

Publication number Publication date
JP2005524641A (en) 2005-08-18
EP1476466A1 (en) 2004-11-17
WO2003068817A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2003300308A1 (en) Controlled polymerization
AU2003267643A1 (en) Telecommunications
AU2003304128A1 (en) Electroactive polymers
AU2003247137A1 (en) Syringe pump
AU2003293082A1 (en) Antioxidant-functionalized polymers
AU2003283559A1 (en) Traffic management architecture
AU2003287064A1 (en) Wide bandwidth led curing light
AU2003302648A1 (en) Luminescent glass
AU2003299189A1 (en) Patch
AU2003215180A1 (en) Photoelectrochemical molecular comb
AU2003254874A1 (en) Adhesive patch
AU2003242218A1 (en) Patch
AU2003277556A1 (en) Syringe pump
AU2003270734A1 (en) Rna-mediated gene modulation
AU2003245406A1 (en) Polymerization process
AU2003272878A1 (en) Adhesive patch
AU2003276026A1 (en) Bicalutamide forms
AU2003260794A1 (en) Immunotherapy using modulators of notch signalling
AU2003205555A1 (en) Management of mucosal viscosity by tff monomer peptides
AU2003235725A1 (en) Flexible glass/polymer composite
AU2003208530A1 (en) Luminous tile
AU2002367039A1 (en) Discharge lamp
AU2003236344A1 (en) Piston pump
AU2003303475A1 (en) Polymerization processes
AU2003300416A1 (en) Multiplex polymer ligation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase